Editorial: Novelties in acute myeloid leukemia: from biology to clinical applications.

The editorial "Novelties in acute myeloid leukemia: from biology to clinical applications" discusses recent advances in understanding acute myeloid leukemia (AML) biology and treatment. Topics covered include new prognostic biomarkers, therapeutic strategies such as CAR-T cells and targeted drugs, and the impact of mutations like RAS on cell metabolism. The research highlights the importance of personalized treatment approaches and the ongoing need for novel therapies for AML patients. [Extracted from the article]